SCHEMBL8765703

SCHEMBL8765703

Oc1cccc(OCCCCCCc2ccccc2)c1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.60
DRD4 P21917 2/20 0.60
DRD3 P35462 2/20 0.60
ADRA1D P25100 1/20 0.60
ADRA1A P35348 1/20 0.60
ADRA1B P35368 1/20 0.60
CHRNB2 P17787 1/20 0.51
CHRNA4 P43681 1/20 0.51
FFAR1 O14842 1/20 0.51
CNR1 P21554 3/20 0.50
CNR2 P34972 3/20 0.50
PLA2G4B P0C869 1/20 0.49
NAAA Q02083 1/20 0.49
MTNR1A P48039 1/20 0.48
MTNR1B P49286 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16528761 0.98 DRD2 (0.61) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL573713 0.93 DRD2 (0.63) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL25197061 0.88 DRD2 (0.65) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL661821 0.88 DRD2 (0.65) DRD2DRD4DRD3ADRA1DADRA1A
Butylbenzyl SCHEMBL28097889 0.88 CNR2 (0.55) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL10367030 0.87 CNR2 (0.59) FFAR1CNR1CNR2PLA2G4BNAAA
SCHEMBL16902832 0.86 CHRNB2 (0.65) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL9009814 0.86 CHRNB2 (0.65) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL16902831 0.86 CHRNB2 (0.65) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL16902829 0.86 CHRNB2 (0.65) DRD2DRD4DRD3ADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12053537-B2 Reduction of stinging sensation on skin SYMRISE AG (DE) 2024-08-06 US claimed
CN-108472220-B Reducing the perception of skin stinging 西姆莱斯股份公司 2022-06-17 CN claimed
EP-3373895-B1 REDUCTION OF STINGING SENSATION ON SKIN SYMRISE AG (DE) 2020-08-19 EP claimed
EP-3373895-A1 REDUCTION OF STINGING SENSATION ON SKIN Symrise AG (DE) 2018-09-19 EP claimed
EP-2842607-B1 A skin and/or hair whitening mixture SYMRISE AG (DE) 2018-05-30 EP claimed
WO-2017080625-A1 REDUCTION OF STINGING SENSATION ON SKIN SYMRISE AG (DE) 2017-05-18 WO claimed
US-20150064122-A1 SKIN AND/OR HAIR WHITENING MIXTURE SYMRISE AG (DE) 2015-03-05 US claimed
EP-2842607-A1 A skin and/or hair whitening mixture Symrise AG (DE) 2015-03-04 EP claimed
CN-119345088-A Whitening nanoemulsion and preparation method thereof 广东鼎尖国际生物科技有限公司 2025-01-24 CN disclosed
US-12053537-B2 Reduction of stinging sensation on skin SYMRISE AG (DE) 2024-08-06 US disclosed
EP-4401843-A1 SOLID CLEANSING COMPOSITIONS AND METHODS FOR THE SAME Colgate-Palmolive Company (US) 2024-07-24 EP disclosed
WO-2023043703-A1 SOLID CLEANSING COMPOSITIONS AND METHODS FOR THE SAME COLGATE-PALMOLIVE COMPANY (US) 2023-03-23 WO disclosed
US-20230079706-A1 Solid Cleansing Compositions and Methods for the Same COLGATE-PALMOLIVE COMPANY (US) 2023-03-16 US disclosed
CN-108472220-B Reducing the perception of skin stinging 西姆莱斯股份公司 2022-06-17 CN disclosed
WO-2018001485-A1 MEDICAMENT AND COSMETIC COMPOSITION COMPRISING RESORCINOL DERIVATIVES SYMRISE AG (DE) 2018-01-04 WO disclosed
WO-2017080625-A1 REDUCTION OF STINGING SENSATION ON SKIN SYMRISE AG (DE) 2017-05-18 WO disclosed
CN-104414869-A SKIN AND/OR HAIR WHITENING MIXTURE SYMRISE AG 2015-03-18 CN disclosed
US-20150064122-A1 SKIN AND/OR HAIR WHITENING MIXTURE SYMRISE AG (DE) 2015-03-05 US disclosed
EP-2842607-A1 A skin and/or hair whitening mixture Symrise AG (DE) 2015-03-04 EP disclosed
EP-0778267-A1 SULFONAMIDE DERIVATIVES AND INSECTICIDE, MITICIDE AND NEMATICIDE CONTAINING THE SAME OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1997-06-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12053537-B2 Reduction of stinging sensation on skin STING1, TYR, CUTA DRD2 2146/4885DRD4 2316/4885DRD3 1906/4885
US-20150064122-A1 SKIN AND/OR HAIR WHITENING MIXTURE TYR, AHR, CYP1B1 DRD2 515/4885DRD4 434/4885DRD3 264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.